A $15B Clinical AI Company. Now Go Find Its Published Accuracy Rate.
OpenEvidence raised $250M at $15B, confirmed by its founder. It is not an OpenAI product — OpenAI ships a competitor. And it does publish an accuracy number: 100% on USMLE. The only figures for hard cases come from outside researchers, and they are 34–41%.